Identification and characterization of process-related impurities of trans-resveratrol

Scientia Pharmaceutica

Volumn 81, Issue 3, 2013, Pages 683-695

  Sivakumar, Balasubramanian ^a   Murugan, Raman ^a   Baskaran, Annamalai ^a   Pandharinath Khadangale, Bhausaheb ^a   Murugan, Saravanan ^a   Palanisamy Senthilkumar, Udayampalayam ^a  

^a Orchid Chemicals and Pharmaceuticals Ltd   (India)

Author keywords

HPLC; Impurities; LC MS; NMR; Resveratrol; Structural elucidation; Structure characterization

Indexed keywords

1,3 (DIBENZYLOXY) 5 [ 2 (4 BENZYLOXYPHENYL)ETHENYL]BENZENE; 2 BENZYL 5 [ 2 (4 HYDROXYPHENYL)ETHENYL]BENZENE 1,3 DIOL; 3 (BENZYLOXY) 5 [ 2 (4 HYDROXYPHENYL)ETHENYL]PHENOL; 5 [ 2 [4 (BENZYLOXY)PHENYL]ETHENYL]BENZENE 1,3 DIOL; BENZENE DERIVATIVE; RESVERATROL; UNCLASSIFIED DRUG;

ARTICLE; DRUG IMPURITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ULTRAVIOLET SPECTROSCOPY;

EID: 84884564402     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1301-17     Document Type: Article

References (14)

1. Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, Van Breemen RB, Mo S, Li Y, Cushman M. Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites. J Med Chem. 2010; 53: 5033-5043. http://dx.doi.org/10.1021/jm100274c
2. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5: 493-506. http://dx.doi.org/10.1038/nrd2060
3. Koch C, Reichling J, Schneeleb J, Schnitzler P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. 2008; 15: 71-78. http://dx.doi.org/10.1016/j.phymed.2007.09.003
4. Cardile V, Chillemi R, Lombardo L, Sciuto S. Antiproliferative activity of methylated analogues of E and Z-resveratrol. Z Naturforsch. 2007; 62: 189-195. http://www.ncbi.nlm.nih.gov/pubmed/17542483
5. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem. 1997; 30: 91-113. http://dx.doi.org/10.1016/S0009-9120(96)00155-5
6. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275: 218-220. http://dx.doi.org/10.1126/science.275.5297.218
7. International Conference on Harmonisation. ICH Q3A (R), Impuritites in new drug substances, February 2002.
8. International Conference on Harmonisation. ICH Q3A, validation of analytical procedure: Methodology. 6, November 1996.
9. Orsini F, Verotta L, Lecchi M, Restano R, Curia G, Redaelli E, Wanke E. Resveratrol Derivatives and Their Role as Porassium Channels Modulators. J Nat Prod. 2004; 67: 421-426. http://dx.doi.org/10.1021/np0303153
10. Moreno-Labnda JF, Mallavia R, Rez-Fons LP, Lizama V, Saura D, Micol V. Determination of Piceid and Resveratrol in Spanish Wines Deriving from Monastrell (Vitis vinifera L.) Grape Variety. J Agric Food Chem. 2004; 52: 5396-5403. http://dx.doi.org/10.1021/jf049521m
11. Wang DG, Liu WY, Chen, GT. A simple method for the isolation and purification of resveratrol from Polygonum cuspidatum. J Pharm Anal; 2013; 3: 241-247. http://dx.doi.org/10.1016/j.jpha.2012.12.001
12. Koh D, Park KH, Jung J, Yang H, Mok KH, Lim Y. Complete assignment of the 1H and 13C NMR spectra of resveratrol derivatives. Magn Res Chem. 2001; 39: 768-770. http://dx.doi.org/10.1002/mrc.910
13. An Improved Process For the Preparation of Trans-Resveratrol. Indian Patent no: 24405, 2010. http://ipindiaservices.gov.in/patentsearch/GrantedSearch/ReportProjectPopUp.aspx?Appl_No=151/MAS/2003&Pbl_No=151/MAS/2003&Pat_No=244056
14. Silverstein RM, Bassler CG, Morrill CT. Spectrometric Identification of Organic Compounds, 5th ed. John Wiley & Sons, Inc., Singapore, 1991.